nach oben

European Journal of Clinical Microbiology & Infectious Diseases

Erschienen in:

14.12.2017 | Original Article

Risk factors and clinical outcomes of hypervirulent Klebsiella pneumoniae induced bloodstream infections

verfasst von: Jiayang Li, Jianan Ren, Weiping Wang, Gefei Wang, Guosheng Gu, Xiuwen Wu, Ying Wang, Mei Huang, Jieshou Li

Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases | Ausgabe 4/2018

Einloggen, um Zugang zu erhalten

Abstract

The prevalence of hypervirulent Klebsiella pneumoniae (hvKP) is high in China, but clinical characteristics and outcomes of hvKP induced bloodstream infections (BSIs) are not clear. The purpose of the present study was to determine the risk factors and clinical outcomes of hvKP-BSIs in populations admitted in a teaching hospital of Nanjing, China. The genetic characteristics and antibiotic resistance patterns of the hvKP strains were further analyzed. A retrospective study was conducted in 143 patients with K. pneumoniae BSIs at Jinling Hospital in China from September 2015 to December 2016. A positive polymerase chain reaction (PCR) amplification of the plasmid-borne rmpA (p-rmpA) and aerobactin (iucA) was identified as hvKP. Overall, 24.5% (35/143) of K. pneumoniae isolates were hvKP. Multivariate analysis implicated diabetes mellitus (OR = 3.356) and community-acquired BSIs (OR = 4.898) as independent risk factors for hvKP-BSIs. The 30-day mortality rate of the hvKP-BSIs group was 37.1% (13/35) compared with 40.7% (44/108) in the cKP-BSIs control group (P = 0.706). The KPC-producing isolates (OR = 2.851), underlying disease with gastrointestinal fistula (OR = 3.054), APACHE II score ≥ 15 (OR = 6.694) and Pitt bacteremia score ≥ 2 (OR = 6.232) at infection onset were independent predictors for 30-day mortality of K. pneumoniae bacteremia patients. A high percentage (57.1%, 20/35) of KPC-producing isolates was observed among hvKP strains and ST11 was dominant in hvKP strains (17/35, 48.6%). KPC-producing hvKP is emerging, indicating the importance of epidemiologic surveillance and clinical awareness of this pathogen.

Jarvis WR, Munn VP, Highsmith AK, Culver DH, Hughes JM (1985) The epidemiology of nosocomial infections caused by Klebsiella pneumoniae. Infect Control 6(2):68–74CrossRefPubMed

Ocampo AM, Chen L, Cienfuegos AV, Roncancio G, Chavda KD, Kreiswirth BN, Jimenez JN (2015) A two-year surveillance in five Colombian tertiary care hospitals reveals high frequency of non-CG258 clones of carbapenem-resistant Klebsiella pneumoniae with distinct clinical characteristics. Antimicrob Agents Chemother 60(1):332–342. https://doi.org/10.1128/aac.01775-15 CrossRefPubMedPubMedCentral

Jiang Y, Wei Z, Wang Y, Hua X, Feng Y, Yu Y (2015) Tracking a hospital outbreak of KPC-producing ST11 Klebsiella pneumoniae with whole genome sequencing. Clin Microbiol Infect 21(11):1001–1007. https://doi.org/10.1016/j.cmi.2015.07.001 CrossRefPubMed

Yang S, Hemarajata P, Hindler J, Li F, Adisetiyo H, Aldrovandi G, Sebra R, Kasarskis A, MacCannell D, Didelot X, Russell D, Rubin Z, Humphries R (2017) Evolution and transmission of carbapenem-resistant Klebsiella pneumoniae expressing the blaOXA-232 gene during an institutional outbreak associated with endoscopic retrograde cholangiopancreatography. Clin Infect Dis 64(7):894–901. https://doi.org/10.1093/cid/ciw876 CrossRefPubMed

Fung CP, Chang FY, Lee SC, Hu BS, Kuo BI, Liu CY, Ho M, Siu LK (2002) A global emerging disease of Klebsiella pneumoniae liver abscess: is serotype K1 an important factor for complicated endophthalmitis? Gut 50(3):420–424CrossRefPubMedPubMedCentral

Siu LK, Yeh KM, Lin JC, Fung CP, Chang FY (2012) Klebsiella pneumoniae liver abscess: a new invasive syndrome. Lancet Infect Dis 12(11):881–887. https://doi.org/10.1016/s1473-3099(12)70205-0 CrossRefPubMed

Liu YC, Cheng DL, Lin CL (1986) Klebsiella pneumoniae liver abscess associated with septic endophthalmitis. Arch Intern Med 146(10):1913–1916CrossRefPubMed

Shon AS, Bajwa RP, Russo TA (2013) Hypervirulent (hypermucoviscous) Klebsiella pneumoniae: a new and dangerous breed. Virulence 4(2):107–118. https://doi.org/10.4161/viru.22718 CrossRefPubMedPubMedCentral

Yao B, Xiao X, Wang F, Zhou L, Zhang X, Zhang J (2015) Clinical and molecular characteristics of multi-clone carbapenem-resistant hypervirulent (hypermucoviscous) Klebsiella pneumoniae isolates in a tertiary hospital in Beijing, China. Int J Infect Dis 37:107–112. https://doi.org/10.1016/j.ijid.2015.06.023 CrossRefPubMed

10.

Li W, Sun G, Yu Y, Li N, Chen M, Jin R, Jiao Y, Wu H (2014) Increasing occurrence of antimicrobial-resistant hypervirulent (hypermucoviscous) Klebsiella pneumoniae isolates in China. Clin Infect Dis 58(2):225–232. https://doi.org/10.1093/cid/cit675 CrossRefPubMed

11.

Liu YM, Li BB, Zhang YY, Zhang W, Shen H, Li H, Cao B (2014) Clinical and molecular characteristics of emerging hypervirulent Klebsiella pneumoniae bloodstream infections in mainland China. Antimicrob Agents Chemother 58(9):5379–5385. https://doi.org/10.1128/aac.02523-14 CrossRefPubMedPubMedCentral

12.

Catalan-Najera JC, Garza-Ramos U, Barrios-Camacho H (2017) Hypervirulence and hypermucoviscosity: two different but complementary Klebsiella spp. phenotypes? Virulence 8(7):1111–1123. https://doi.org/10.1080/21505594.2017.1317412

13.

Lee HC, Chuang YC, Yu WL, Lee NY, Chang CM, Ko NY, Wang LR, Ko WC (2006) Clinical implications of hypermucoviscosity phenotype in Klebsiella pneumoniae isolates: association with invasive syndrome in patients with community-acquired bacteraemia. J Intern Med 259(6):606–614. https://doi.org/10.1111/j.1365-2796.2006.01641.x CrossRefPubMed

14.

Prokesch BC, TeKippe M, Kim J, Raj P, TeKippe EM, Greenberg DE (2016) Primary osteomyelitis caused by hypervirulent Klebsiella pneumoniae. Lancet Infect Dis 16(9):e190–e195. https://doi.org/10.1016/s1473-3099(16)30021-4 CrossRefPubMed

15.

Mazloum M, Le Meur M, Barnaud G, Messika J (2016) Hypermucoviscous Klebsiella pneumoniae pneumonia: follow the string! Intensive Care Med 42(12):2092–2093. https://doi.org/10.1007/s00134-016-4363-y CrossRefPubMed

16.

Yan Q, Zhou M, Zou M, Liu WE (2016) Hypervirulent Klebsiella pneumoniae induced ventilator-associated pneumonia in mechanically ventilated patients in China. Eur J Clin Microbiol Infect Dis 35(3):387–396. https://doi.org/10.1007/s10096-015-2551-2 CrossRefPubMed

17.

Luo Y, Wang Y, Ye L, Yang J (2014) Molecular epidemiology and virulence factors of pyogenic liver abscess causing Klebsiella pneumoniae in China. Clin Microbiol Infect 20(11):O818–O824. https://doi.org/10.1111/1469-0691.12664 CrossRefPubMed

18.

Zhang Y, Zhao C, Wang Q, Wang X, Chen H, Li H, Zhang F, Li S, Wang R, Wang H (2016) High prevalence of Hypervirulent Klebsiella pneumoniae infection in China: geographic distribution, clinical characteristics, and antimicrobial resistance. Antimicrob Agents Chemother 60(10):6115–6120. https://doi.org/10.1128/aac.01127-16 CrossRefPubMedPubMedCentral

19.

Compain F, Babosan A, Brisse S, Genel N, Audo J, Ailloud F, Kassis-Chikhani N, Arlet G, Decre D (2014) Multiplex PCR for detection of seven virulence factors and K1/K2 capsular serotypes of Klebsiella pneumoniae. J Clin Microbiol 52(12):4377–4380. https://doi.org/10.1128/jcm.02316-14 CrossRefPubMedPubMedCentral

20.

Chen Z, Liu M, Cui Y, Wang L, Zhang Y, Qiu J, Yang R, Liu C, Zhou D (2014) A novel PCR-based genotyping scheme for clinical Klebsiella pneumoniae. Future Microbiol 9(1):21–32. https://doi.org/10.2217/fmb.13.137 CrossRefPubMed

21.

Poirel L, Walsh TR, Cuvillier V, Nordmann P (2011) Multiplex PCR for detection of acquired carbapenemase genes. Diagn Microbiol Infect Dis 70(1):119–123. https://doi.org/10.1016/j.diagmicrobio.2010.12.002 CrossRefPubMed

22.

Russo TA, Olson R, MacDonald U, Beanan J, Davidson BA (2015) Aerobactin, but not yersiniabactin, salmochelin, or enterobactin, enables the growth/survival of hypervirulent (hypermucoviscous) Klebsiella pneumoniae ex vivo and in vivo. Infect Immun 83(8):3325–3333. https://doi.org/10.1128/iai.00430-15 CrossRefPubMedPubMedCentral

23.

Zhang Y, Ma Y, Ye L, Luo Y, Yang J (2014) Prevalence and antimicrobial susceptibility of hypervirulent Klebsiella pneumoniae isolates in China. Clin Infect Dis 58(10):1493–1494. https://doi.org/10.1093/cid/ciu110 CrossRefPubMed

24.

Yu WL, Lee MF, Chen CC, Tang HJ, Ho CH, Chuang YC (2017) Impacts of hypervirulence determinants on clinical features and outcomes of bacteremia caused by extended-spectrum beta-lactamase-producing Klebsiella pneumoniae. Microb Drug Resist 23(3):376–383. https://doi.org/10.1089/mdr.2016.0018 CrossRefPubMed

25.

Hsu CR, Lin TL, Chen YC, Chou HC, Wang JT (2011) The role of Klebsiella pneumoniae rmpA in capsular polysaccharide synthesis and virulence revisited. Microbiology 157(Pt 12):3446–3457. https://doi.org/10.1099/mic.0.050336-0 CrossRefPubMed

26.

Wu H, Li D, Zhou H, Sun Y, Guo L, Shen D (2017) Bacteremia and other body site infection caused by hypervirulent and classic Klebsiella pneumoniae. Microb Pathog 104:254–262. https://doi.org/10.1016/j.micpath.2017.01.049 CrossRefPubMed

27.

Cubero M, Grau I, Tubau F, Pallares R, Dominguez MA, Linares J, Ardanuy C (2016) Hypervirulent Klebsiella pneumoniae clones causing bacteraemia in adults in a teaching hospital in Barcelona, Spain (2007-2013). Clin Microbiol Infect 22(2):154–160. https://doi.org/10.1016/j.cmi.2015.09.025 CrossRefPubMed

28.

Guo Y, Wang S, Zhan L, Jin Y, Duan J, Hao Z, Lv J, Qi X, Chen L, Kreiswirth BN, Wang L, Yu F (2017) Microbiological and clinical characteristics of hypermucoviscous Klebsiella pneumoniae isolates associated with invasive infections in China. Front Cell Infect Microbiol 7:24. https://doi.org/10.3389/fcimb.2017.00024 PubMedPubMedCentral

29.

Pomakova DK, Hsiao CB, Beanan JM, Olson R, MacDonald U, Keynan Y, Russo TA (2012) Clinical and phenotypic differences between classic and hypervirulent Klebsiella pneumonia: an emerging and under-recognized pathogenic variant. Eur J Clin Microbiol Infect Dis 31(6):981–989. https://doi.org/10.1007/s10096-011-1396-6 CrossRefPubMed

30.

Togawa A, Toh H, Onozawa K, Yoshimura M, Tokushige C, Shimono N, Takata T, Tamura K (2015) Influence of the bacterial phenotypes on the clinical manifestations in Klebsiella pneumoniae bacteremia patients: a retrospective cohort study. J Infect Chemother 21(7):531–537. https://doi.org/10.1016/j.jiac.2015.04.004 CrossRefPubMed

31.

Gu D, Dong N, Zheng Z, Lin D, Huang M, Wang L, Chan EW, Shu L, Yu J, Zhang R, Chen S (2017) A fatal outbreak of ST11 carbapenem-resistant hypervirulent Klebsiella pneumoniae in a Chinese hospital: a molecular epidemiological study. Lancet Infect Dis. https://doi.org/10.1016/s1473-3099(17)30489-9

32.

Yu WL, Ko WC, Cheng KC, Lee CC, Lai CC, Chuang YC (2008) Comparison of prevalence of virulence factors for Klebsiella pneumoniae liver abscesses between isolates with capsular K1/K2 and non-K1/K2 serotypes. Diagn Microbiol Infect Dis 62(1):1–6. https://doi.org/10.1016/j.diagmicrobio.2008.04.007 CrossRefPubMed

33.

Siu LK, Huang DB, Chiang T (2014) Plasmid transferability of KPC into a virulent K2 serotype Klebsiella pneumoniae. BMC Infect Dis 14:176. https://doi.org/10.1186/1471-2334-14-176 CrossRefPubMedPubMedCentral

34.

Qi Y, Wei Z, Ji S, Du X, Shen P, Yu Y (2011) ST11, the dominant clone of KPC-producing Klebsiella pneumoniae in China. J Antimicrob Chemother 66(2):307–312. https://doi.org/10.1093/jac/dkq431 CrossRefPubMed

35.

Zhang Y, Zeng J, Liu W, Zhao F, Hu Z, Zhao C, Wang Q, Wang X, Chen H, Li H, Zhang F, Li S, Cao B, Wang H (2015) Emergence of a hypervirulent carbapenem-resistant Klebsiella pneumoniae isolate from clinical infections in China. J Inf Secur 71(5):553–560. https://doi.org/10.1016/j.jinf.2015.07.010

36.

Tumbarello M, Trecarichi EM, De Rosa FG, Giannella M, Giacobbe DR, Bassetti M, Losito AR, Bartoletti M, Del Bono V, Corcione S, Maiuro G, Tedeschi S, Celani L, Cardellino CS, Spanu T, Marchese A, Ambretti S, Cauda R, Viscoli C, Viale P (2015) Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study. J Antimicrob Chemother 70(7):2133–2143. https://doi.org/10.1093/jac/dkv086 CrossRefPubMed

37.

Fraenkel-Wandel Y, Raveh-Brawer D, Wiener-Well Y, Yinnon AM, Assous MV (2016) Mortality due to blaKPC Klebsiella pneumoniae bacteraemia. J Antimicrob Chemother 71(4):1083–1087. https://doi.org/10.1093/jac/dkv414 CrossRefPubMed

38.

Girometti N, Lewis RE, Giannella M, Ambretti S, Bartoletti M, Tedeschi S, Tumietto F, Cristini F, Trapani F, Gaibani P, Viale P (2014) Klebsiella pneumoniae bloodstream infection: epidemiology and impact of inappropriate empirical therapy. Medicine (Baltimore) 93(17):298–309. https://doi.org/10.1097/md.0000000000000111 CrossRef

39.

Gomez-Simmonds A, Greenman M, Sullivan SB, Tanner JP, Sowash MG, Whittier S, Uhlemann AC (2015) Population structure of Klebsiella pneumoniae causing bloodstream infections at a New York city tertiary care hospital: diversification of multidrug-resistant isolates. J Clin Microbiol 53(7):2060–2067. https://doi.org/10.1128/jcm.03455-14 CrossRefPubMedPubMedCentral

Titel: Risk factors and clinical outcomes of hypervirulent Klebsiella pneumoniae induced bloodstream infections
verfasst von: Jiayang Li
Jianan Ren
Weiping Wang
Gefei Wang
Guosheng Gu
Xiuwen Wu
Ying Wang
Mei Huang
Jieshou Li
Publikationsdatum: 14.12.2017
Verlag: Springer Berlin Heidelberg
Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases / Ausgabe 4/2018
Print ISSN: 0934-9723
Elektronische ISSN: 1435-4373
DOI: https://doi.org/10.1007/s10096-017-3160-z

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

25.04.2024 | Hypotonie | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Risk factors and clinical outcomes of hypervirulent Klebsiella pneumoniae induced bloodstream infections

Abstract

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Viel Bewegung in der Parkinsonforschung

Adjuvante Immuntherapie verlängert Leben bei RCC

Update Innere Medizin

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2018

Prosthetic valve endocarditis caused by Propionibacterium species: a national registry-based study of 51 Swedish cases

OXA-48-like carbapenemases producing Enterobacteriaceae in different niches

Usefulness of a single-assay chemiluminescence test (Tularaemia VIRCLIA IgG + IgM monotest) for the diagnosis of human tularemia. Comparison of five serological tests

Evaluation of the Copan Myco-TB kit for the decontamination of respiratory samples for the detection of Mycobacteria

Oral teicoplanin versus oral vancomycin for the treatment of severe Clostridium difficile infection: a prospective observational study

Predictors of colonization with Staphylococcus species among patients scheduled for cardiac and orthopedic interventions at tertiary care hospitals in north-eastern Germany—a prevalence screening study

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Viel Bewegung in der Parkinsonforschung

Adjuvante Immuntherapie verlängert Leben bei RCC

Update Innere Medizin